Investors Similar to RAPT Therapeutics, Inc.
Discover 20 alternative investors with similar investment focus, vc structure, and track record.
Target Investor
RAPT Therapeutics, Inc.
RAPT Therapeutics is a clinical-stage immunology-based biopharmaceutical company that discovers, develops, and commercializes novel oral small molecule therapies. The company focuses on addressing significant unmet needs in inflammatory and immunologic diseases, including oncology. They utilize a proprietary drug discovery and development engine to create highly selective small molecules designed to modulate critical immune responses.
Similar Investors
Showing 20 results
About This Comparison
This alternatives page shows investors with similar characteristics to RAPT Therapeutics, Inc., including similar vc structure, comparable investment focus, and track record. Use this page to discover alternative investors for your funding strategy, investor mapping, or competitive analysis.
Investors are ranked by total score, which reflects portfolio size, investment activity, and market presence on StartupHub.ai. Learn more about each investor by clicking their profile to see portfolio companies, investment rounds, and detailed information.
StartupHub.ai provides free access to investor profiles, funding data, and startup intelligence. No paywall, no enterprise subscription required.